Prompt and early diagnosis of respiratory pathogens that cause severe illness is critical to help inform patient management, treatment decisions, and preventing the spread of disease. Confidence in testing results allows clinicians and patients to make informed decisions—including seeking medical care and/or avoiding contact with other people. While many testing options are available for respiratory testing, molecular techniques including PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.
PCR and RADT are two testing technologies used to detect COVID-19. It’s important to understand what they each do best and how their attributes fit your testing scenario. The infographic below summarizes their differences.
Download infographic Browse kits
The US Food and Drug Administration (FDA) authorized the Applied Biosystems TaqPath COVID-19 Kit for emergency use just days after the World Health Organization (WHO) declared COVID-19 a global pandemic and later received the CE mark in Europe. Since then, Thermo Fisher Scientific has continued to grow and enhance the TaqPath testing portfolio by adding diagnostic kits for detection of COVID-19 in asymptomatic cases, direct from saliva, and simultaneous detection of flu A and flu B—all while enabling detection of all currently known variants and maintaining an uninterrupted product supply.
Trusted worldwide—over half a billion tests distributed globally
Single test—detect SARS-CoV-2 and influenza (flu) A and B viruses
Sensitive detection for symptomatic and asymptomatic cases
Fast direct from saliva + RNase P and mutation resilient
For Emergency Use Authorization (EUA) only. For Prescription Use Only. For In Vitro Diagnostic Use.
Interested in the effect of mutations on sensitivity of the TaqPath COVID-19 diagnostic tests? Learn more ›
Looking for research solutions for investigating respiratory pathogens? Click below to view Research Use Only (RUO) products covering viral, bacterial, and fungal targets in targeted or syndromic panels.
For Research Use Only. Not for use in diagnostic procedures.
The testing kits above are compatible with our portfolio of instruments and consumables listed below. Contact us for more information on the capabilities and compatibilities of multiple instruments and formats.
Watch our on-demand webinars to learn more about how our COVID-19 Diagnostics Testing Solutions address challenges, or browse our full webinar library.
Read our blog discussing how influenza is an underestimated threat, or browse through our full blog library.
For Emergency Use Authorization (EUA) Only. For Prescription Use Only. For In Vitro Diagnostic Use.